drugset
drugset / Trial / NCT00211796

Divalproex Sodium ER in Adult Autism

NCT00211796 ↗

Phase 4 Completed 10 enrolled Montefiore Medical Center
Non-randomizedSingle-groupOpen-labelTreatment

Summary

12-week open label treatment trial of divalproex sodium extended release (Depakote ER) in 10 patients with a diagnosis of autism. Our objective is to determine how well these patients can tolerate the prescribed doses and what added benefits can be attributed to divalproex sodium ER.

Timeline

Start
2005-04
Primary completion
2007-04
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Divalproex Sodium Small molecule — —

Indications

autism